WEBINAR: Are You Choosing the Right Model?

A Guide to Selecting Your Next Immuno-Oncology Model

Thursday, June 22, 2017 @ 11am EDT | 4pm BST | 5pm CEST

Join our webinar to discover the wide range of in vivo immuno-oncology preclinical models available, and what to consider when choosing the correct model for your studies. Learn how current models are being used to progress combination regimens, including dual immunotherapies, and I/O agents plus other treatment modalities.

NEW WHITE PAPER: Translational Platforms to Model Pre-Diabetes, Diabetes, and Diabetic Complications

This White Paper explores a unique platform of highly translational models recapitulating multiple aspects of disease progression as seen in humans, for preclinical efficacy studies.

ON-DEMAND WEBINAR: Translational Platforms to Model Pre-Diabetes, Diabetes, and Complications

Join our webinar to discover the development and utility of CrownBio's unique continuum of translational platforms modeling diabetes and metabolic syndrome pathophysiology, progression, and complications. Learn how these platforms are predicting the efficacy and safety of anti-diabetic therapies in humans.

CONFERENCE: ASCO Annual Meeting 2017

June 2-6, 2017 - McCormick Place, Chicago, IL

At ASCO 2017 we are bringing together recognized scientific leaders in the field of Oncology Precision Medicine to discuss the latest combination therapy approaches, translational oncology, and immuno-oncology findings. We hope that you'll join us there at Booth #17017

CONFERENCE: American Diabetes Association 77th Scientific Sessions

June 9-13, 2017 - San Diego Convention Center, San Diego, CA

Join us at ADA 2017 Booth #131 to discuss our unique end to end continuum of translational in vivo platforms to overcome current challenges in modeling human diabetes in animal models. We're also presenting scientific posters of our recent research advances.

SYMPOSIUM: Translational Oncology Drug Discovery - From Target to Patient

June 21, 2017 - Terrass Hotel, Paris, France

Crown Bioscience invites you to attend a symposium featuring the latest Translational Oncology Drug Discovery advances and models, with a key focus on immuno-oncology. Join the discussion on how translational oncology and immuno-oncology platforms can be applied to expedite novel cancer agents efficiently from basic research to clinical use.

National Cancer Research Month

Save $500 on recombinant cell lines

Fast track your efficacy studies, cell viability assays, or antibody and inhibitor screening with any of our 60 recombinant cell lines developed specifically for preclinical cancer research.

Didn't Make it to AACR 2017?

Read and download all of our 14 posters now!

Clarity with

Recognize your next clinical candidate when you see it.

Our Translational Platforms enable our clients to identify the right patients for the right treatment. Having models which more accurately mimic human disease and population dynamics are key to successfully translating promising compounds into successful clinical candidates, whether treating Oncology or Diabetes related diseases.

Magnify your

Understand the mechanisms of disease.

Our scientific acumen and experience will give you a deeper understanding of not just the pharmacological profile of your compound, but more importantly, a clear understanding of which compounds to progress into the clinic. Take a look at our publications to get a deeper understanding of the depth of our scientific expertise.

Begin with the
end insight

Connecting science to patients.

We help our clients solve some of today's most pressing problems in oncology, cardiovascular, and metabolic disease by answering some of the most challenging questions about human biology.


Models of Obesity


CrownBio’s preclinical Translational Technology Platforms provide spontaneous & diet-induced obesity (DIO) models, to support the transition of new agents into the clinic.

Learn More


Oncology Databases


Our unique databases provide a curated source of well-characterized models available to use for drug discovery including PDX models, cell lines, and syngeneic models.

Learn More


Diabetes Models


Models of both Type 1 and Type 2 diabetes, including conventional, as well as unique, highly translatable models for in vivo efficacy studies of antidiabetic agents.

Learn More

Latest from our Blog

May 25, 2017

Preclinical Immuno-Oncology Models 101

The recent breakthrough of checkpoint inhibitors in oncology has demonstrated that the immune system is a critical player in fighting cancer, and that immunotherapies are a key new treatment class.

Read More

May 25, 2017

Preclinical Immuno-Oncology Models 101

The recent breakthrough of checkpoint inhibitors in oncology has demonstrated that the immune...

Read More

May 23, 2017

When to Use Conventional Cell Line Derived Xenograft Models

With the creation and increased use of “new” xenograft models (such as patient-derived...

Read More

May 18, 2017

Can We Develop Translational Platforms that Model Multiple Aspects of Human Diabetes?

A significant challenge in the development of new anti-diabetic therapies is the lack of...

Read More

May 12, 2017

When to add Patient-Derived Xenografts (PDX) to Preclinical Drug Development Programs

Anyone who works in preclinical and translational oncology drug development will have seen or...

Read More

May 9, 2017

The Beginners Guide to Patient-Derived Xenograft (PDX) Models

Most preclinical researchers have heard the term patient-derived xenograft (or PDX), but many in...

Read More

Upcoming Events

May 23 - 25, 2017

Biomed Israel 2017 16th National Life Sciences and Technology Week

Tel Aviv, Israel


May 24 - 25, 2017

CrownBio University: Lunch & Learn Series

Boston, MA


June 2 - 6, 2017

ASCO 2017 Annual Meeting

Booth #17017


June 9 - 13, 2017

American Diabetes Association

San Diego, CA - Booth #131


June 21, 2017

Symposium: Oncology Drug Discovery, Translating from Target to Patient

Terrass Hotel - Paris, France


June 23, 2017

SAPA-GP Annual Conference

Sheraton Valley Forge Hotel, PA 


June 28 - July 2, 2017

Bio Taiwan

Taipei Taiwan (Booth #N202)


June 29, 2017

Israeli Immunology Society Symposium

Hebrew University, Jerusalem

July 18, 2017

From Bench to Bedside

Burlington, Vermont

July 18 - 20, 2017

Tumor Models Boston

The Colonnade Hotel, Boston, MA


September 2017 TBD

Crown Bioscience Symposium

San Diego, CA

September 6 - 9, 2017

Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

Mainz/Frankfurt, Germany


September 29 - 30, 2017

25th Annual SAPA Conference

New Jersey